| Title : Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis - Roy_2016_CNS.Drugs_30_209 |
| Author(s) : Roy S , Benedict RH , Drake AS , Weinstock-Guttman B |
| Ref : CNS Drugs , 30 :209 , 2016 |
| Abstract : |
| PubMedSearch : Roy_2016_CNS.Drugs_30_209 |
| PubMedID: 26884145 |
| Title : Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis - Roy_2016_CNS.Drugs_30_209 |
| Author(s) : Roy S , Benedict RH , Drake AS , Weinstock-Guttman B |
| Ref : CNS Drugs , 30 :209 , 2016 |
| Abstract : |
| PubMedSearch : Roy_2016_CNS.Drugs_30_209 |
| PubMedID: 26884145 |
| Title : Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis - Roy_2016_CNS.Drugs_30_209 |
| Author(s) : Roy S , Benedict RH , Drake AS , Weinstock-Guttman B |
| Ref : CNS Drugs , 30 :209 , 2016 |
| Abstract : |
| PubMedSearch : Roy_2016_CNS.Drugs_30_209 |
| PubMedID: 26884145 |